+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

EGFR overexpression and radiation response in glioblastoma multiforme



EGFR overexpression and radiation response in glioblastoma multiforme



International Journal of Radiation Oncology Biology Physics 51(2): 410-418



Purpose: Recent studies have suggested relative radioresistance in glioblastoma multiforme (GM) tumors in older patients, consistent with their shorter survival. Two common molecular genetic abnormalities in GM are age related: epidermal growth factor receptor (EGFR) overexpression in older patients and p53 mutations in younger patients. We tested whether these abnormalities correlated with clinical heterogeneity in GM response to radiation treatment. Methods and Materials: Radiographically assessed radiation response (5-level scale) was correlated with EGFR immunoreactivity, p53 immunoreactivity, and p53 exon 5-8 mutation status in 170 GM patients treated using 2 prospective clinical protocols. Spearman rank correlation and proportional-odds ordinal regression were used for univariate and multivariate analysis. Results: Positive EGFR immunoreactivity predicted poor radiographically assessed radiation response (p=0.046). Thirty-three percent of tumors with no EGFR immunoreactivity had good radiation responses (>50% reduction in tumor size by CT or MRI), compared to 18% of tumors with intermediate EGFR staining and 9% of tumors with strong staining. There was no significant relationship between p53 immunoreactivity or mutation status and radiation response. Significant relationships were noted between EGFR score and older age and between p53 score or mutation status and younger age. Conclusion: The observed relative radioresistance of some GMs is associated with overexpression of EGFR.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 010504537

Download citation: RISBibTeXText

PMID: 11567815

DOI: 10.1016/s0360-3016(01)01609-1


Related references

Overexpression of the epidermal growth factor receptor (EGFR), as determined by EGFR immunostaining on tissue microarrays, fails to demonstrate prognostic value for patients with glioblastoma multiforme: a report from RTOG 7401, 7918, 8302, 8409, 9006, 9305, 9602, and 9806. International Journal of Radiation Oncology*biology*physics 54(2-Supp-S): 96-0, 2002

Uniform MDM2 overexpression in a panel of glioblastoma multiforme cell lines with divergent EGFR and p53 expression status. Anticancer Research 26(6b): 4191-4194, 2007

EGFR gene overexpression retained in an invasive xenograft model by solid orthotopic transplantation of human glioblastoma multiforme into nude mice. Cancer Investigation 29(3): 229-239, 2011

Age and radiation response in glioblastoma multiforme. Neurosurgery 49(6): 1288-97; Discussion 1297-8, 2002

Age and Radiation Response in Glioblastoma Multiforme. Neurosurgery 49(6): 1288-1298, 2001

Nimotuzumab, a humanized monoclonal antibody specific for the EGFR, in combination with temozolomide and radiation therapy for newly diagnosed glioblastoma multiforme: First results in Chinese patients. Asia-Pacific Journal of Clinical Oncology 12(1): E23-E29, 2016

Next generation sequencing and molecular imaging identify EGFR mutation and amplification in a glioblastoma multiforme patient treated with an EGFR inhibitor: a case report. Oncotarget 8(30): 50305-50313, 2017

Overexpression of the epidermal growth factor receptor , as determined by EGFR immunostaining on tissue microarrays, fails to demonstrate prognostic value for patients with glioblastoma multiforme A report from RTOG 7401, 7918, 8302, 8409, 9006, 9305, 9602 and 9806. International Journal of Radiation Oncology Biology Physics 54(2 Suppl.): 96, 2002

Genetic basis of clinical radiation response in glioblastoma multiforme. Proceedings of the American Association for Cancer Research Annual Meeting 42: 666, 2001

Radiation response and survival time in patients with glioblastoma multiforme. Journal of Neurosurgery 84(3): 442-448, 1996

Radiation-induced glioblastoma multiforme in children treated for medulloblastoma with characteristics of both medulloblastoma and glioblastoma multiforme. Journal of Pediatric Hematology/Oncology 32(7): E272-E278, 2010

In situ analysis of mutant EGFRs prevalent in glioblastoma multiforme reveals aberrant dimerization, activation, and differential response to anti-EGFR targeted therapy. Molecular Cancer Research 10(3): 428-440, 2012

Radiation response and extent of resection predict survival in glioblastoma multiforme. Journal of Neurosurgery 82(2): 352A, 1995

Integrin 3 Overexpression Suppresses Tumor Growth in a Human Model of Gliomagenesis: Implications for the Role of 3 Overexpression in Glioblastoma Multiforme. Cancer Research 64(8): 2751-2758, 2004

An accelerated senescence response to radiation in wild-type p53 glioblastoma multiforme cells. Journal of Neurosurgery 105(1): 111-118, 2006